Exactech Announces Investor Presentation at Canaccord Genuity Growth Conference
09:45 EDT 7 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Exactech,
Inc. (Nasdaq: EXAC),
a developer and producer of bone and joint restoration products for hip,
knee, shoulder, spine and biologic materials will update investors at
the 2012 Canaccord Genuity Growth Conference in...
Other Sources for this Article
Exactech Inc.
Investor contacts
Jody Phillips, 352-377-1140
Chief
Financial Officer
or
Hawk Associates
Julie Marshall or
Frank Hawkins, 305-451-1888
E-mail: exactech@hawkassociates.com
More From BioPortfolio on "Exactech Announces Investor Presentation at Canaccord Genuity Growth Conference"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
